Literature DB >> 33456587

The Genetic Background of Central Serous Chorioretinopathy: A Review on Central Serous Chorioretinopathy Genes.

Konstantinos Giannopoulos1,2, Maria Gazouli3, Klio Chatzistefanou1, Anthi Bakouli4, Marilita M Moschos1.   

Abstract

Central serous chorioretinopathy is characterized by neurosensory detachment of the central retina secondary to fluid leakage through the retinal pigment epithelium. Though it has an incidence of 9,9 per 100.000 in men and 1,7 per 100.000 in women, it is the fourth most common retinal disorder. Central serous chorioretinopathy patients present with blurred vision, central scotoma, metamorphopsia, micropsia and mild color discrimination. It is usually a self-limited disorder with nearly none or minimal visual impairment but in some patients the disease persists and may cause severe visual impairment. Central serous chorioretinopathy pathophysiology is not well understood. Choroid, retinal pigment epithelium and hormonal pathways seem to play important roles in central serous chorioretinopathy pathophysiology. Also, familial cases of the disease indicate that there is a genetic background. The identification of certain disease genes could lead to the development of better diagnostic and therapeutic approaches for central serous chorioretinopathy patients. © The author(s).

Entities:  

Keywords:  Central Serous Chorioretinopathy; Diagnosis; Genes; Pathophysiology; Review

Year:  2021        PMID: 33456587      PMCID: PMC7806452          DOI: 10.7150/jgen.55545

Source DB:  PubMed          Journal:  J Genomics


  57 in total

Review 1.  Central serous chorioretinopathy: an update on pathogenesis and treatment.

Authors:  M Gemenetzi; G De Salvo; A J Lotery
Journal:  Eye (Lond)       Date:  2010-10-08       Impact factor: 3.775

2.  Comparison of efficacy and safety between half-fluence and full-fluence photodynamic therapy for chronic central serous chorioretinopathy.

Authors:  Joo Young Shin; Se Joon Woo; Hyeong Gon Yu; Kyu Hyung Park
Journal:  Retina       Date:  2011-01       Impact factor: 4.256

Review 3.  Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis.

Authors:  Alejandra Daruich; Alexandre Matet; Ali Dirani; Elodie Bousquet; Min Zhao; Nicolette Farman; Frédéric Jaisser; Francine Behar-Cohen
Journal:  Prog Retin Eye Res       Date:  2015-05-27       Impact factor: 21.198

4.  GENETIC RISK FACTORS IN ACUTE CENTRAL SEROUS CHORIORETINOPATHY.

Authors:  Danial Mohabati; Rosa L Schellevis; Elon H C van Dijk; Lebriz Altay; Sascha Fauser; Carel B Hoyng; Eiko K De Jong; Camiel J F Boon; Suzanne Yzer
Journal:  Retina       Date:  2019-12       Impact factor: 4.256

Review 5.  Central serous chorioretinopathy: update on pathophysiology and treatment.

Authors:  Benjamin Nicholson; Jason Noble; Farzin Forooghian; Catherine Meyerle
Journal:  Surv Ophthalmol       Date:  2013 Mar-Apr       Impact factor: 6.048

6.  Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy.

Authors:  Min Zhao; Isabelle Célérier; Elodie Bousquet; Jean-Claude Jeanny; Laurent Jonet; Michèle Savoldelli; Olivier Offret; Antoine Curan; Nicolette Farman; Frédéric Jaisser; Francine Behar-Cohen
Journal:  J Clin Invest       Date:  2012-06-11       Impact factor: 14.808

Review 7.  Adrenomedullin in the eye.

Authors:  Reiko Udono-Fujimori; Tetsuo Udono; Kazuhito Totsune; Makoto Tamai; Shigeki Shibahara; Kazuhiro Takahashi
Journal:  Regul Pept       Date:  2003-04-15

8.  Digital indocyanine green videoangiography of central serous chorioretinopathy.

Authors:  D R Guyer; L A Yannuzzi; J S Slakter; J A Sorenson; A Ho; D Orlock
Journal:  Arch Ophthalmol       Date:  1994-08

9.  Risk factors for central serous chorioretinopathy: a case-control study.

Authors:  Robert Haimovici; Sean Koh; David R Gagnon; Todd Lehrfeld; Sarah Wellik
Journal:  Ophthalmology       Date:  2004-02       Impact factor: 12.079

10.  Cadherin 5 is regulated by corticosteroids and associated with central serous chorioretinopathy.

Authors:  Carl Schubert; Anders Pryds; Shemin Zeng; Yajing Xie; K Bailey Freund; Richard F Spaide; John C Merriam; Irene Barbazetto; Jason S Slakter; Stanley Chang; Inger C Munch; Arlene V Drack; Jasmine Hernandez; Suzanne Yzer; Joanna E Merriam; Allan Linneberg; Michael Larsen; Lawrence A Yannuzzi; Robert F Mullins; Rando Allikmets
Journal:  Hum Mutat       Date:  2014-07       Impact factor: 4.700

View more
  2 in total

1.  Associations of Single-Nucleotide Polymorphisms in Slovenian Patients with Acute Central Serous Chorioretinopathy.

Authors:  Peter Kiraly; Andrej Zupan; Alenka Matjašič; Polona Jaki Mekjavić
Journal:  Genes (Basel)       Date:  2021-12-25       Impact factor: 4.096

2.  Clinical Characteristics and Multimodal Imaging Findings of Central Serous Chorioretinopathy in Women versus Men.

Authors:  Elodie Bousquet; Héloïse Torres-Villaros; Julien Provost; Martine Elalouf; Anthony Gigon; Irmela Mantel; Aurélie Timsit; Francine Behar-Cohen
Journal:  J Clin Med       Date:  2022-03-19       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.